Verastem promotes Robert Forrester to president
This article was originally published in Clinica
Verastem, a company developing stem cell treatments for recurring cancers, has promoted Robert Forrester to president in addition to chief operating officer. Prior to joining Cambridge, Massachusetts-based Verastem in May 2011, Mr Forrester had served as CEO, COO and CFO at both private and public biotechnology companies and as a managing director at Dutch private bank, MeesPierson.
You may also be interested in...
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.
Biopharmaceutical companies doubled-down on rare disease treatments during the last five years, thanks to a potent combination of scientific discovery and appealing business incentives.